State Street’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

State Street’s Portfolio NMRD Stock Details NMRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-53,666	Closed	-$12.1K	–	4476
2023 Q4	$12.1K	Hold	53,666	–	–	﹤0.01%	4384
2023 Q3	$17.3K	Hold	53,666	–	–	﹤0.01%	4458
2023 Q2	$49.9K	Hold	53,666	–	–	﹤0.01%	4418
2023 Q1	$47K	Buy	53,666 +18,042	+51%	+$23.3K	﹤0.01%	4515
2022 Q4	$60.6K	Hold	35,624	–	–	﹤0.01%	4514
2022 Q3	$74K	Hold	35,624	–	–	﹤0.01%	4561
2022 Q2	$92K	Hold	35,624	–	–	﹤0.01%	4561
2022 Q1	$156K	Buy	35,624 +2,935	+9%	+$12.3K	﹤0.01%	4474
2021 Q4	$149K	Sell	32,689 -49,258	-60%	-$265K	﹤0.01%	4463
2021 Q3	$493K	Sell	81,947 -20,242	-20%	-$146K	﹤0.01%	3985
2021 Q2	$1.06M	Sell	102,189 -3,792	-4%	-$36.2K	﹤0.01%	3659
2021 Q1	$810K	Buy	105,981 +41,600	+65%	+$275K	﹤0.01%	3666
2020 Q4	$243K	Sell	64,381 -2,500	-4%	-$9.64K	﹤0.01%	3725
2020 Q3	$237K	Sell	66,881 -1,072	-2%	-$6.26K	﹤0.01%	3645
2020 Q2	$629K	Buy	+67,953	New	+$485K	﹤0.01%	3510

Other funds holding NMRD

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

State Street's NMRD Position: Q1 2024 in Review

State Street sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q1 2024, closing a stake of 53,666 shares — an estimated $12.1K sold.

State Street first reported a position in NMRD in Q2 2020 and held it in 15 quarters. The position peaked at $1.06M in Q2 2021. 2 funds tracked by Wall St. Rank hold NMRD as of Q1 2024.

State Street reported no remaining Nemaura Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
State Street sold 53,666 Nemaura Medical, Inc. Common Stock shares in Q1 2024, an estimated $12.1K.
State Street first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
State Street's Nemaura Medical, Inc. Common Stock position peaked at $1.06M in Q2 2021.
2 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.